Contact UsTwo Pershing Square 2300 Main Street, Suite 170 Kansas City MO 64108
Two Pershing Square
2300 Main Street, Suite 170
Kansas City, MO 64108
Telephone: (816) 221-6600
Toll Free: 1 (877) 284-6600
Fax: (816) 221-6612
In February 2020, the U.S. Judicial Panel on Multidistrict Litigation consolidated all of the Zantac lawsuits in the U.S. District Court for the Southern District of Florida under Judge Robin Rosenberg.
Once a best-selling drug for more than 60 million Americans experiencing heart burn, Zantac (ranitidine) has now been pulled from the US market after several third-party tests found unsafe levels of a contaminant known as N-nitrosodimethyalmine (NDMA).
FDA Requests Removal of Zantac
The US Food and Drug Administration approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR), which is used in patients with ulcerative colitis.
This new warning, issued July 26, 2019, comes just a few months after the first warning issued February 25, 2019.
Torrent Pharmaceuticals is recalling an additional 36 lots of Losartan potassium tablets and 68 lots Losartan potassium/hydrochlorothiazide tablets. This is the fourth expansion of the original recall posted in December 2018 of blood pressure medications manufactured by the company.
Bayer and Johnson & Johnson, the companies who make and sell the blood thinner Xarelto, have reached a settlement in 25,000 lawsuits. While the companies have not admitted liability, they have agreed to pay a $775 million dollar settlement.
In May 2017, the FDA issued a safety warning indicating that Invokana, used to treat diabetes, could increase the risk of leg and foot amputations. This means that the drug now carries a boxed warning about the amputation risks. This is the strongest label warning that the FDA can require.
A growing number of Proton Pump Inhibitor (PPI) lawsuits have been filed against the manufacturers of PPI medications. Plaintiffs allege that as a result of taking a PPI for gastric acid-related conditions, they have been diagnosed with kidney injuries including Acute Interstitial Nephritis (AIN), chronic kidney disease and renal failure.
Originally scheduled to start in February, the first Bellwether trial for the blood thinner, Xarelto, will now begin on April 24, 2017 in the Eastern District of Louisiana.
One of the kidney problems caused by Proton Pump Inhibitors like Nexium, Prilosec, and Prevacid may be Acute Interstitial Nephritis. Acute Interstitial Nephritis (AIN) is characterized by inflammatory cells infiltrating the interstitium of the kidney and may lead to acute kidney failure. Delays in diagnosis and persistent use of the drug causing AIN (such as Nexium, Prilosec, or Prevacid), can cause Chronic Kidney Failure.
Nexium, Prevacid and Prilosec, some of the most prescribed medicines in the world, may increase your risk for kidney disease.